Report of 3 Cases of Hairy Cell Leukemia Treated with 2-Chlorodeoxyadenosine.
- Author:
Dae Young CHEUNG
1
;
Seok LEE
;
Yoo Jin KIM
;
Yoon Hee PARK
;
Seung Ki KWOK
;
Hye Jung LEE
;
Hee Je KIM
;
Dong Wook KIM
;
Jong Wook LEE
;
Woo Sung MIN
;
Chun Choo KIM
Author Information
1. Department of Internal Medicine, College of Medicine, The Catholic University of Korea, Seoul, Korea. leeseok@catholic.ac.kr
- Publication Type:Case Report
- Keywords:
Hairy cell leukemia;
2-chlorodeoxyadenosine;
complete remission
- MeSH:
B-Lymphocytes;
Cladribine*;
Cytoplasm;
Diagnosis;
Humans;
Infusions, Intravenous;
Leukemia, Hairy Cell*;
Lymphoproliferative Disorders;
Pentostatin;
Prognosis;
Splenomegaly
- From:Korean Journal of Hematology
2002;37(4):292-296
- CountryRepublic of Korea
- Language:Korean
-
Abstract:
Hairy cell leukemia (HCL) is an uncommon chronic B-cell lymphoproliferative disorder characterized by cytopenia, splenomegaly and mononuclear cells displaying cytoplasmic projections. Diagnosis is based on the distinctive hairy cell morphology and immunological profile. In the last 10 to 15 years the prognosis of patients with HCL has improved considerably following the use of purine analogues such as deoxycoformycin and 2-chlorodeoxyadenosine (2-CdA). We report 3 patients with HCL who were treated with 2-CdA at a daily dosage of 0.1mg/kg by continuous intravenous infusion for 7 days. After 1 or 2 courses of treatment, all patients achieved complete remission and are still alive in disease-free status.
